Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data. - Wikidata - awgldk - TriplyDB

Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.

Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.

http://www.wikidata.org/entity/Q33474263

about

Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.ToF-SIMS imaging of lipids and lipid related compounds in Drosophila brain.Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research Assessing and treating forgetfulness and cognitive problems in adults with HIV The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder.Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study.

P2860

Q33579178-3BD5D236-998A-40F2-A6B1-EEEFEDB06CD9 Q35533686-A1A6741E-D316-4753-8A17-608BE6DDDE5A Q36616443-9E552C46-D13E-4B5A-B963-0CC759C8E5A5 Q36666859-D6F879E5-951E-4ACC-9959-42E5E272F730 Q37169223-A6D78A38-04FA-4F13-BABB-79C4DB126A94 Q46535632-B45D0B64-02D0-4E16-9805-4A3DFB37548A Q47305172-B91BC647-1A45-4EA3-99AD-44EB31533390

P2860

Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.

http://www.wikidata.org/entity/Q33474263

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Methylphenidate has positive h ...... lyceridemic effects: new data.

@ast

Methylphenidate has positive h ...... lyceridemic effects: new data.

@en

type

label

Methylphenidate has positive h ...... lyceridemic effects: new data.

@ast

Methylphenidate has positive h ...... lyceridemic effects: new data.

@en

prefLabel

Methylphenidate has positive h ...... lyceridemic effects: new data.

@ast

Methylphenidate has positive h ...... lyceridemic effects: new data.

@en

P1433

Q33474263-D92E0EE9-C1E8-4A4F-951D-591C5296F98F

P1476

Q33474263-1F0161CB-2FA5-49D8-BF27-0A7E46EB78FC

P2093

Q33474263-56EECC23-5AA4-4CD7-8E85-773C436F5678

Q33474263-72F50CEF-25A6-4288-9270-CD7788D7F7F3

Q33474263-AE2D0A00-E19C-4758-920E-4D18F0558804

Q33474263-C14D41B6-CD81-4466-9E7B-86A0534D3BD7

Q33474263-C739E01B-DB23-4E49-9C3E-CE02AEB99629

P2860

Q33474263-0F4B41CF-251E-4C3A-ADE1-FB83C5FBD1C2

Q33474263-1B64B51D-707B-47AB-A7AA-35B7D85D2895

Q33474263-36CD0781-65C9-4AC4-9FF3-8166567FB36B

Q33474263-4380DE7F-6D4A-4950-B92E-A828F61EFB89

Q33474263-46F02B9E-0EA8-4698-A7D3-0119F5C6AE2B

Q33474263-50220C19-B9B8-42B0-986A-F37E62CABB42

Q33474263-9856CB55-9554-4EB9-AB47-595D832E10E5

Q33474263-AA35C257-3FE8-405F-8567-839D0A931688

Q33474263-B0690C51-7FDF-4FBE-99EE-F1882061E992

Q33474263-D2CA1403-1EF9-4858-9CB3-9BD4A1F38355

P304

Q33474263-AF4B90B8-E5FF-43F0-BEA1-1DE6EA7885E1

P31

Q33474263-9E2488F2-DF7C-44BE-8987-B4D184AA113E

P356

Q33474263-3C3CC62B-F928-4D0A-BAA4-C862CAA08CC3

P433

Q33474263-27B2A299-44CC-4C26-B244-B7D38D8180C0

P478

Q33474263-0448D195-E2CD-4139-BA47-5B65B4384392

P577

Q33474263-25AD2453-7B21-4100-9BD1-0C191FC76A5F

P5875

Q33474263-B8789C11-C432-4B89-8616-2FB7C1096B1E

P698

Q33474263-9B11B023-3F0C-4E8D-93E0-04322A352495

P921

Q33474263-181204E2-0C99-43F3-9F95-F588931C50A9

P356

0091270009336736

P1433

The Journal of Clinical Pharmacology

P1476

Methylphenidate has positive h ...... lyceridemic effects: new data.

@en

P2093

Alexander Rabinovich

http://www.w3.org/2001/XMLSchema#string

Gideon Charach

http://www.w3.org/2001/XMLSchema#string

Itamar Grosskopf

http://www.w3.org/2001/XMLSchema#string

Moshe Weintraub

http://www.w3.org/2001/XMLSchema#string

Nehemia Kaysar

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management]

Drug treatment of conduct disorder in young people.

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects.

Cardiovascular risk factor levels and their relationships with overweight and fat distribution in children: the Fleurbaix Laventie Ville Santé II study

Therapies for narcolepsy with or without cataplexy: evidence-based review.

Valproate prevents the induction and the expression of MK-801 sensitization.

Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivity disorder.

Decreased serum glucose levels after initiation of methylphenidate in a patient status post-cerebellar tumour resection: a potential interaction with glipizide.

P304

848-851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270009336736

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26317802

http://www.w3.org/2001/XMLSchema#string

P698

19553406

http://www.w3.org/2001/XMLSchema#string

P921

hypocholesterolemia